Maryland Subject | Drugs | Senate | Introduced

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDSB497Intro

Sine Die
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss]
2024-03-04
Withdrawn by Sponsor
MDSB761Intro

Sine Die
Requiring each testing facility in the State to be licensed by the Department of Agriculture to use animals in research, education, or testing; establishing requirements for the use and treatment of dogs or cats by a testing facility; prohibiting a t...
[Detail][Text][Discuss]
2024-02-13
To Senate Education, Energy, and the Environment Committee
MDSB47Intro

Sine Die
Establishing prohibitions and requirements regarding the sale of diet pills to individuals under the age of 18 years; requiring the Maryland Department of Health to develop a notice with information about the potential health risks of diet pills; and...
[Detail][Text][Discuss]
2024-02-12
Withdrawn by Sponsor
MDSB911Intro

Sine Die
Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words "Gene structure- or function-modifying product" and all potent...
[Detail][Text][Discuss]
2024-02-09
To Senate Finance Committee
MDSB1137Intro

Sine Die
Requiring the Maryland Department of Health to develop a list of diet pills, make the list publicly accessible on or before January 1, 2025, and update the list on a quarterly basis.
[Detail][Text][Discuss]
2024-02-09
To Senate Rules Committee
MDSB349Intro

Sine Die
Authorizing certain retirees who began State service before July 1, 2011, to be eligible for prescription drug benefits in the State Employee and Retiree Health and Welfare Benefits Program; specifying that prescription drug benefits shall be discont...
[Detail][Text][Discuss]
2024-02-06
To Senate Budget and Taxation Committee
MDSB801Intro

Sine Die
Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders...
[Detail][Text][Discuss]
2024-02-06
To Senate Budget and Taxation Committee
MDSB1016Intro

Sine Die
Requiring health care providers who are authorized to prescribe to double the amount of each drug prescribed for a child if a parent of the child presents the prescriber with a court order of joint legal custody with a right of medical decision makin...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB989Intro

Sine Die
Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments, coinsurance, and deductibles for a covered prescription epinephrine injector to not mo...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB1019Intro

Sine Die
Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB990Intro

Sine Die
Prohibiting the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, health maintenance organizations, and managed care organizations from applying a prior authorization requirement, step therapy protocol, or fail...
[Detail][Text][Discuss]
2024-02-06
To Senate Finance Committee
MDSB1109Intro

Sine Die
Altering certain provisions of law relating to the sale and distribution of certain hemp-derived compounds and cannabinoid products for the purpose of prohibiting certain persons from selling or distributing "intoxicating cannabinoids" as defined und...
[Detail][Text][Discuss]
2024-02-04
To Senate Rules Committee
MDSB626Intro

Sine Die
Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app...
[Detail][Text][Discuss]
2024-02-02
To Senate Finance Committee
MDSB754Intro

Sine Die
Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss]
2024-02-02
To Senate Finance Committee
MDSB844Intro

Sine Die
Establishing that certain firefighters, fire fighting instructors, rescue squad members, advanced life support unit members, and members of the Office of the State Fire Marshal demonstrate disablement for purposes of workers' compensation and are dee...
[Detail][Text][Discuss]
2024-02-02
To Senate Finance Committee
MDSB427Intro

Sine Die
Authorizing a community-based organization, with the approval of the Maryland Department of Health, to establish an Overdose and Infectious Disease Prevention Services Program to provide a location for the consumption of preobtained drugs, provide st...
[Detail][Text][Discuss]
2024-01-31
To Senate Finance Committee
MDSB582Intro

Sine Die
Requiring licensees that sell cigarettes, other tobacco products, or electronic smoking devices at retail to keep in stock and offer for sale at retail at least one kind of nicotine replacement therapy product and to post certain signs.
[Detail][Text][Discuss]
2024-01-29
To Senate Finance Committee
MDSB388Intro

Sine Die
Requiring the Governor in fiscal year 2025 and each fiscal year thereafter to include in the annual budget bill an appropriation of at least $1,000,000 for the Prescription Drug Affordability Fund which provides funding for the Board; and requiring t...
[Detail][Text][Discuss]
2024-01-24
To Senate Finance Committee
MDSB526Intro

Sine Die
Prohibiting certain pharmacy benefits managers from requiring a beneficiary to use a specific pharmacy or entity for a specialty drug if the drug is dispensed by a physician, used in the treatment of a certain condition, and meets other requirements;...
[Detail][Text][Discuss]
2024-01-24
To Senate Finance Committee
MDSB443Intro

Sine Die
Authorizing an individual to request aid in dying by making certain requests; establishing requirements and prohibitions governing aid in dying, including requirements related to requests for aid in dying, consulting physicians, mental health assessm...
[Detail][Text][Discuss]
2024-01-23
To Senate Judicial Proceedings Committee
MDSB246Intro

Sine Die
Establishing the Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program to authorize pharmacists and health care providers to prescribe or dispense nPEP under certain circumstances; and authorizing the Maryland Department of Health to...
[Detail][Text][Discuss]
2024-01-10
To Senate Finance Committee
MDSB235Intro

Sine Die
Altering the definition of "dispenser" for purposes of the Prescription Drug Monitoring Program to include certain licensed veterinarians when dispensing controlled substances for animals in the usual course of providing professional services; and pr...
[Detail][Text][Discuss]
2024-01-09
To Senate Finance Committee
Syndicate content
feedback